<meta http-equiv="content-type" content="text/html; charset=ISO-8859-1" /><br>Title: Ranking FDA Risks: The Medical Devices Case</br><br>Author: Robin Keller, University of California-Irvine, Irvine, CA, United States of America, lrkeller@uci.edu</br><br>Coauthor(s): Yitong Wang</br><br>Year: 2012</br><br>Abstract: This talk focuses on a medical devices case study. Keller served as a decision analyst on the committee charged with suggesting how the FDA can compare risks across product categories (foods, cosmetics, drugs, etc.). The NRC book proposed a multiple objective decision analytic approach to ranking risks: A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration is at http://dels.nas.edu/Report/Risk-Characterization-Framework-Decision/13156.</br>